CMS Open Payments · Program Year 2024
Avita Medical Americas, Llc
Avita Medical Americas, Llc reported $1,602,377.84 across General Payments, Research, and Ownership to 2,776 physicians and teaching hospitals across 2,860 transactions.
- $1.6M
- All-tracks total
- 2,860
- Transactions
- 2,776
- Recipients
- −$118.8K
- General Payments vs PY2023
Avita Medical Americas, Llc reported $1,602,377.84 across all CMS Open Payments tracks (General + Research + Ownership) to 2,776 physicians and teaching hospitals in Program Year 2024 - ranking #505 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $544,951.27, averaging $577.23 per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer avita-medical-americas-llc Avita Medical Americas, Llc
$1.6M · #505/1,925 · 0.0% industry · PY2024
- TOT $1.6M
- RANK #505
- SHARE 0.0%
- TXN 2,860
- RCP 2,776
- CAT 5
- GEN $545.0K
- ΔGEN −$118.8K
- TOP1 7.2%
- PY 2024
Volume peers
Nearest volume peer: Grifols Shared Services North America, Inc. ($1.6M)
Avita Medical Americas, Llc sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Avita Medical Americas, Llc's CMS-reported General Payments decreased by $118.8K (−17.9%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: AVITA MEDICAL AMERICAS, LLCPY2023: AVITA MEDICAL AMERICAS, LLCPY2024: Avita Medical Americas, Llc. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $663,712.16
- PY2024
- $544,951.27
What the Data Shows for Avita Medical Americas, Llc
In Program Year 2024, Avita Medical Americas, Llc reported $1,602,377.84 in payments to 2,776 physicians and teaching hospitals across 2,860 individual transactions, an average of $560.27 per transaction and $577.23 per recipient. That total places Avita Medical Americas, Llc at rank #505 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
The 5-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $170.4K, accounting for 31.3% of this company's General Payments and 90 transactions.
General Payment Breakdown by Type
"Consulting Fee" leads Avita Medical Americas, Llc's 5-category general-payment breakdown at $170.4K, 31.3% of the reported total.
Avita Medical Americas, Llc reports 5 general-payment categories - the top three are Consulting Fee (31.3%), Food and Beverage (27.5%), and Honoraria (23.4%). The remaining 2 categories make up 17.8% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Avita Medical Americas, Llc divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $170.4K | 90 | 31.3% |
| Food and Beverage | $150.1K | 2,362 | 27.5% |
| Honoraria | $127.5K | 62 | 23.4% |
| Travel and Lodging | $95.4K | 261 | 17.5% |
| Compensation for Services Other Than Consulting | $1.5K | 1 | 0.3% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $158,586.45 (29.1%) of $544,951.27 in this company's General Payments records across 1,562 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Avita Medical Americas, Llc
The five named recipients with the highest reported General Payments from this company
- 1
Ian Valerio
$39,303.03 across 69 reported transactions
- 2
Derek Bell
$32,016.60 across 70 reported transactions
- 3
Carmen Flores
$29,985.83 across 65 reported transactions
- 4
Jeffrey Carter
$29,057.09 across 30 reported transactions
- 5
Rajiv Sood
$28,223.90 across 5 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Avita Medical Americas, Llc's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Avita Medical Americas, Llc.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Avita Medical Americas, Llc.
Showing 6 of 1,924 companies with CMS-reported payment data.
Rigel Pharmaceuticals, Inc.
Ethicon US, LLC
restor3d, inc.
Zavation Medical Products, LLC
Datascope Corp.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.